|
C15ORF42 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.33935093518767E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09700001807533E-09 |
| Normal-vs-Stage2 |
9.85930000000357E-05 |
| Normal-vs-Stage3 |
5.97309979255556E-10 |
| Normal-vs-Stage4 |
3.647200E-04 |
| Stage1-vs-Stage2 |
5.977800E-01 |
| Stage1-vs-Stage3 |
4.200700E-03 |
| Stage1-vs-Stage4 |
1.614290E-02 |
| Stage2-vs-Stage3 |
5.678300E-03 |
| Stage2-vs-Stage4 |
1.278120E-02 |
| Stage3-vs-Stage4 |
1.434640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.71673827667973E-12 |
| Normal-vs-AfricanAmerican |
7.236800E-04 |
| Normal-vs-Asian |
4.676300E-02 |
| Caucasian-vs-AfricanAmerican |
3.492400E-01 |
| Caucasian-vs-Asian |
2.067600E-01 |
| AfricanAmerican-vs-Asian |
4.483800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03870001488815E-09 |
| Normal-vs-Female |
2.84839929420855E-11 |
| Male-vs-Female |
4.556600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.639400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.66009999968963E-07 |
| Normal-vs-Age(61-80Yrs) |
1.38669997706842E-09 |
| Normal-vs-Age(81-100Yrs) |
4.922600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.897000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.197000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.099200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.344200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.973800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.417400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.15189999999144E-05 |
| Normal-vs-Grade 2 |
7.95989996138502E-09 |
| Normal-vs-Grade 3 |
4.81259999629557E-08 |
| Normal-vs-Grade 4 |
9.79110000000061E-05 |
| Grade 1-vs-Grade 2 |
8.791200E-01 |
| Grade 1-vs-Grade 3 |
8.431700E-02 |
| Grade 1-vs-Grade 4 |
9.721300E-03 |
| Grade 2-vs-Grade 3 |
3.946400E-02 |
| Grade 2-vs-Grade 4 |
7.715800E-03 |
| Grade 3-vs-Grade 4 |
6.419800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.67880000001563E-06 |
| Normal-vs-ccB subtype |
2.85216295026203E-13 |
| ccA subtype-vs-ccB subtype |
6.82120000483621E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.16469999977831E-07 |
| Normal-vs-N1 |
6.755200E-04 |
| N0-vs-N1 |
2.008600E-01 |
|
|
